Aerie Pharma (AERI) Misses Q4 EPS by 5c

Aerie Pharma (NASDAQ: AERI) reported Q4 EPS of ($0.92), $0.05 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $12.94 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business
• VNET Group (VNET) Misses Q2 EPS by 164c